PARKINSON’S DISEASE: AN OVERVIEW Living with Parkinson’s Disease Deborah Orloff, MPH, RN Chief Executive Officer Michigan Parkinson Foundation.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Parkinson’s disease Dartington 26 June 2003
Linda Pituch, Patient Services Manager, Parkinson’s Disease Foundation
Evaluation of Movement Disorders
Parkinson’s Finding the cure Presentation
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
An Overview of Conventional and Experimental Treatments
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Neurology and Rehabilitation Target Day Parkinson’s Disease Dr Bruce Covell Amanda Horlor Linda Lloyd.
Parkinson’s disease Interventions Whitney Mundy Dr. Davis.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Prepared by: Muhammad Ibrahim khan BS.PT(Pak), MS.PT(Pak), NCC(AKUH), CHPE(KMU)
Initial Diagnosis and Management of Parkinson’s Disease
Is it a neurodegenerative brain disorder that progresses slowly in most people.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Parkinson’s Disease Busra Berika Yucel
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Huntington Disease Genetic Disorder Project Alaukika Desai AP Biology Period 3.
SYMPTOM CONTROL IN ADVANCED PARKINSON’S DISEASE Vicky Travers PDNSUHMBT April 2012.
DEMENTIA AND ALZHEIMER'S DISEASE. IMPAIRMENT OF BRAIN FUNCTION ( DECLINE IN INTELLECTUAL FUNCTIONING) THAT INTERFERES WITH ROUTINE DAILY ACTIVITIES. MENTAL.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
Joohi Jimenez-Shahed, MD Assistant Professor of Neurology Baylor College of Medicine 8 th Annual IMHO Convention April 30, 2011 – Houston, TX Parkinson’s.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
Therapeutic Exercises Therapeutic Exercises. INTRODUCTION The official definition of physical therapy says “it is the art and science of treatment by.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Drugs Used for Parkinson’s Disease Chapter 15 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Management of Parkinson’s disease (in the acute medical ward) C. M. James MD FRCP FAcadMEd Consultant Physician Withybush Hospital, Pembrokeshire.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
Drugs Used for Parkinson’s Disease
Parkinson’s Disease.
Sleep and Parkinson’s Disease
Understanding Parkinsons Disease
MOVEMENT DISORDERS.
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.
WHAT I NEED TO KNOW AS A PATIENT AND A CAREGIVER
Neurodegenerative diseases
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

PARKINSON’S DISEASE: AN OVERVIEW Living with Parkinson’s Disease Deborah Orloff, MPH, RN Chief Executive Officer Michigan Parkinson Foundation

Background and Definitions Parkinson’s disease was first described by Dr. James Parkinson in his paper “An Essay on the Shaking Palsy” in Slowly progressive neurodegenerative disorder with no identifiable cause. The fourth most common neurodegenerative disease of the elderly Affects about 1% of the population over 55 years of age.

Pathology Massive loss of the pigmented neurons and gliosis, most prominently in the substantia nigra with presence of Lewy bodies. Loss of approximately 80% of these neurons results in the presence of clinical symptoms.

Pathology Courtesy of Kapil D. Sethi, MD Normal PD Courtesy of Kapil D. Sethi, MD

Histology of PD Showing Lewy Body

Disease Onset Average age of onset years Approximately 5% of cases occur before age 40 (young onset) Slowly progressive over years Early symptoms may be: constipation, REM sleep disorder, loss of sense of smell, depression non-specific symptoms: easy fatigability, incoordination, change in writing, pain/tension in one shoulder, depression

Motor Symptoms of PD Resting Tremor Rigidity (Cogwheel) Bradykinesia (slow movement) or Akinesia (absence of movement) Postural Instability (balance and coordination)

Tremor First Sign in 75% of patients Occurs at rest Does not need to be present to make a diagnosis Typically on ones side of body and involves a distal extremity (hand, leg)

Rigidity Stiffness caused by an involuntary increase in muscle tone Can affect all muscle groups Often presents as back, neck or shoulder discomfort Often dismissed as arthritis; referrals to orthopedists initially

Akinesia/Bradykinesia “Absence of Movement” Describes the difficulty Parkinson’s patients have in initiating and executing a motor plan. Early signs include microphagia (small writing) and loss of dexterity. Facial: Drooling, hypomimia (masked face). Vocal: hypophonia (soft voice).

Postural Instability Usually the last motor sign to appear. Often the most disabling and least treatable problem. No single factor alone is responsible. “Freezing” is a form of akinesia which is most problematic during ambulation and often leads to falls.

Non-Motor Symptoms Dysautonomias (problems in functioning of the autonomic nervous system) *constipation *impotence *urinary problems *orthostatic hypotension *regulation of heat *sensory disturbances *problems swallowing *pain

Non-Motor Symptoms, con’t Speech problems Behavioral problems, including: depression anxiety panic attacks agitation Sleep Disorders

Non-Motor Symptoms, cont. Loss of smell Constipation Cognitive (thinking) problems, including dementia Fatigue

PARKINSON’S SYMPTOMS VARIABLE—from person to person VARIABLE—from day to day VARIABLE—response to treatment

Parkinsonism A clinical syndrome characterized by specific motor deficits including tremor, akinesia, bradykinesia, rigidity and postural changes/instability. An underlying cause is usually identified: chemicals (drugs), structural NPH, or possibly a neurodegenerative disorder (PSP, MSA)

Clinical Features That May Suggest a Diagnosis Other Than PD Early onset of postural instability Axial more than appendicular rigidity Poor response to adequate dosages of levodopa Early dementia Supranuclear gaze palsy

Treatment and Intervention Non-pharmacologic Exercise Education Nutrition Group Support

Treatment and Intervention Pharmacologic Intervention Considerations: *Degree of functional impairment *cognitive impairment *Age (potential side effects) *Cost

Treatment and Intervention Newer agents are being introduced at greater ages with success. Research into an effective agent for neuroprotection is ongoing. Neuroprotection remains controversial.

How is P.D. Treated? First Line *rest and relaxation *exercise *stress management *nutrition *rehab therapy–ot, pt, speech *mental health counseling *education *support (e.g. support groups)

Medication Complex: Know action, dosage, side effects, how respond. Used to treat symptoms, not cure. No two people respond the same. Own responses vary. Need to monitor and change medication regime over time.

Medication, con’t Newly diagnosed: may hold off until symptoms interfere May start with low levels and work upwards. May use multiple medications. PD meds may interact with others.

Types of Medications Anticholinergics Levodopa (Sinemet CR, Atamet) Amantadine MAO Inhibitors (NO DEMEROL OR ANTIDEPRESSANTS) Dopamine Receptor Agonists Catechol-O-Methyl Transferase (COMT) Selegeline

Frequent Side Effects of Meds Orthostatic hypotension Memory loss or confusion Agitation Depression Hallucinations and psychosis Sleep disturbances/daytime sleepiness Nausea Motor Fluctuations

Challenges of Medications Timing Monitor and adjust Side effects Complications Drug interactions Cost Frustration Incorporating med regimen into setting

Surgery Surgery does not cure or stop the progression. Destruction of cells Deep brain stimulation Pallidotomy Thalamomtomy Gene transfer (beginning stages) Fetal and adrenal grafting (stem cells) EXPERIMENTAL

Surgical Treatments Deep Brain Stimulation Surgery * Insertion of an electrode into the brain to deliver electrical stimulation which dampens tremor, rigidity, dyskinesia. *Reversible *Sites vary depending on diagnoses

Current Research Cause of PD Restoration Neuro-protection New Pharmacologic Agents Different Modes of Administrating Drugs

Management Physical Therapy Occupational Therapy Speech and Language Therapy Mental Health Counseling

Treatment Goals Reduce incidence and severity of symptoms Maintain independence Work together as a team

IMPLICATIONS FOR CARE Provide information Medication Management Skin Care Elimination (bowel, bladder) Comfort Rest Cognition Mental health Safety Cognition Sleep Communication General Health Family education/support Community Resources

Role: Medication Management Correct dose and time Properly administer Track behavior Drug interactions Swallowing difficulties Report problems Document, communicate

Provide Expert Care : COMMUNICATION Speech production Facial expression Slowed thinking Slowed responses Information processing, including memory, concentration, confusion Stress increases problems Depression Dementia Handwriting Family talks for PWP

Communication, continued Management Assess for hearing problems, also Allow time - patience Quiet environment Positive communicative atmosphere Structure conversations, use familiar words Adult topics and routine Encourage communication Referrals: Speech and Language Pathology Assistive devices

Communication, continued Identify problems Document Communicate to other team members Develop plan that works for PWP and family Evaluate

Safety Management Assess for risks Identify probable causes Review previous incidents Develop plan Monitor outcomes, revise as necessary Referrals: Physical Therapy, Occupational Therapy, Speech and Language Pathology, Dietitian

Safety Management: Ambulation Ambulation Avoid rubber or crepe soled shoes Visual, auditory cues Identify problem areas, e.g. narrow hallways, doors Remove hazards, e.g. area rugs Concentrate on one task at a time Ambulatory aids Avoid pivot turns

ADL’S: MANAGEMENT Symptoms vary/abilities vary Perform tasks at times of optimum functioning Give medications so optimal time for tasks is at peak medication time Frustration = PATIENCE Person with PD/Caregiver Referrals: Occupational Therapy Assistive Devices

Sleep Problems Different sleep problems Assess when person is having difficulty: falling asleep, awakening during the night, early awakening, napping during the day, etc. Difficulty normally moving in bed Other problems lead to interrupted sleep, including other medical problems, depression, anxiety, pain, RLS May be related to medications

Sleep Problems: Management Sleep hygiene Medications Alter PD medications Treat depression Physical aids, e.g. satin sheets

Special Issues in LTC Settings Connecting with health professional knowledgeable about management of Parkinson’s disease. Medication management. Complexity of care and course. Hospitalization. Communication/cognition issues. Maintaining in mainstream of life. Family interactions. End of Life issues.

Objectives in Long Term Care Assist individual and family to obtain optimal functioning: physically, emotionally, spiritually. Provide highest quality of care to assist individual to achieve a state of wellness consistent with the quality of life desired by the patient. Assist individual and family to achieve a satisfactory end of life experience.

Where to get help Michigan Parkinson Foundation Telegraph, Suite 150 Bingham Farms, MI ;